tradingkey.logo
tradingkey.logo
Search

Tactile Systems Technology Inc

TCMD
Add to Watchlist
31.350USD
+0.700+2.28%
Close 07/02, 13:00ETQuotes delayed by 15 min
707.14MMarket Cap
35.56P/E TTM

Tactile Systems Technology Inc

31.350
+0.700+2.28%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

+2.28%

5 Days

+11.96%

1 Month

+28.43%

6 Months

+14.42%

Year to Date

+8.10%

1 Year

+209.48%

Key Figures
30.810Open
31.420High
382.95KVolume
35.56P/E TTM
20.36P/E Dynamic
--Dividend TTM
1.71%Turnover Ratio
30.650Prev. Close
29.840Low
8.99MTurnover
41.48P/E Static
3.21P/B
0.00%Div Yield TTM
7.35%ROA
37.77052wk High
1.71Volume Ratio
16.96MNet Profit
22.44MShares
0.8817EPS TTM
0.84Beta
9.59%ROE
9.41552wk Low
5.15%Amplitude
75.75%Gross Margin
707.14MMarket Cap
9.86Reward/Risk
2.61%Risk Rate

Key Insights

Tactile Systems Technology Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 39 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 39.50.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Tactile Systems Technology Inc's Score

Industry at a Glance

Industry Ranking
39 / 204
Overall Ranking
113 / 4565
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Tactile Systems Technology Inc Highlights

StrengthsRisks
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company that manufactures and distributes medical devices for the treatment of patients with chronic diseases at home. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. It markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. It also offers Kylee, a free mobile application that helps patients learn about lymphedema.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 20.08% year-on-year.
Overvalued
The company’s latest PE is 35.56, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 24.21M shares, decreasing 9.57% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 158.76K shares of this stock.

Analyst Rating

Based on 5 analysts
Buy
Current Rating
20.500
Target Price
+55.07%
Upside Space

Tactile Systems Technology Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Tactile Systems Technology Inc Info

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company that manufactures and distributes medical devices for the treatment of patients with chronic diseases at home. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. It markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. It also offers Kylee, a free mobile application that helps patients learn about lymphedema.
Ticker SymbolTCMD
CompanyTactile Systems Technology Inc
CEODodd (Sheri L)
Websitehttps://www.tactilemedical.com/

FAQs

What is the current price of Tactile Systems Technology Inc (TCMD)?

The current price of Tactile Systems Technology Inc (TCMD) is 31.35.

What is the symbol of Tactile Systems Technology Inc?

The ticker symbol of Tactile Systems Technology Inc is TCMD.

What is the 52-week high of Tactile Systems Technology Inc?

The 52-week high of Tactile Systems Technology Inc is 37.77.

What is the 52-week low of Tactile Systems Technology Inc?

The 52-week low of Tactile Systems Technology Inc is 9.41.

What is the market capitalization of Tactile Systems Technology Inc?

The market capitalization of Tactile Systems Technology Inc is 703.46M.

Is Tactile Systems Technology Inc (TCMD) currently rated as Buy, Hold, or Sell?

According to analysts, Tactile Systems Technology Inc (TCMD) has an overall rating of Buy, with a price target of 39.50.

What is the Earnings Per Share (EPS TTM) of Tactile Systems Technology Inc (TCMD)?

The Earnings Per Share (EPS TTM) of Tactile Systems Technology Inc (TCMD) is 0.83.